Kristin Williamson - Concepedia

Author

Kristin Williamson

Also Known As

K WILLIAMSON, KRISTIN M. WILLIAMSON, KRISTIN WILLIAMSON, Kristin M Williamson, Kristin M. Williamson, Kristin Williamson

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Brigham and Women's Hospital Clinical Research Institute University of North Carolina at Chapel Hill Yale University

About

Kristin Williamson is an author at Novartis (United States) specializing in heart failure, emergency medicine, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	20
2	Emergency Medicine	1	1	20
3	Cardiology	1	1	20
4	Cardiovascular Disease	1	1	20
5	Heart Failure	1	1	20

Kristin Williamson

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction James L. Januzzi, Margaret F. Prescott, Javed Butler, JAMA	2019	601
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure Robert J. Mentz, Jonathan H. Ward, Adrian F. Hernandez, Journal of the American College of Cardiology	2023	149
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF Muthiah Vaduganathan, Robert J. Mentz, Brian Claggett, European Heart Journal	2023	110
Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers* Kristin Williamson, J. Herbert Patterson, Robert H. McQueen, Clinical Pharmacology & Therapeutics	1998	97
Digoxin Toxicity Kristin Williamson, K. Thrasher, K. B. Fulton, Archives of Internal Medicine	1998	69
Lack of Gender Differences and Large Intrasubject Variability in Cytochrome P450 Activity Measured by Phenotyping with Dextromethorphan Jeannine S. McCune, Celeste Lindley, Jodi L. Decker, The Journal of Clinical Pharmacology	2001	59
Effect of Fluoxetine on Carvedilol Pharmacokinetics, CYP2D6 Activity, and Autonomic Balance in Heart Failure Patients Donald W. Graff, Kristin Williamson, John A. Pieper, The Journal of Clinical Pharmacology	2001	41
Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction Sean Murphy, Margaret F. Prescott, Alan S. Maisel, Circulation Heart Failure	2021	38
The Effects of Fluvastatin, a CYP2C9 Inhibitor, on Losartan Pharmacokinetics in Healthy Volunteers Amy M. Meadowcroft, Kristin Williamson, J. Herbert Patterson, The Journal of Clinical Pharmacology	1999	37
Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction Ileana L. Piña, Alexander Camacho, Nasrien E. Ibrahim, JACC Heart Failure	2020	31

Page 1